{"id":"W2604005355","doi":"10.1200/jco.2017.35.4_suppl.609","title":"A phase IB study of the combination of selumetinib (AZD6244; ARRY-142886) and cyclosporin A (CsA) in patients with advanced solid tumors with an expansion cohort in metastatic colorectal cancer (mCRC).","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Selumetinib; Medicine; KRAS; Colorectal cancer; Internal medicine; Oncology; Rash; Wnt signaling pathway; MEK inhibitor; Cancer; Oxaliplatin; Regorafenib; Pharmacology; MAPK/ERK pathway; Kinase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001020333,0.001428551,0.001568955,0.0004698105,0.0004199698,0.000905913,0.0008470106,0.001032828,0.003263794],"category_scores_gemma":[0.0005198036,0.000548822,0.001172388,0.000405604,0.0007343034,0.0008238028,0.0003511453,0.003134625,0.0009773751],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001051066,"about_ca_system_score_gemma":0.001473834,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001122642,"about_ca_topic_score_gemma":0.003635486,"domain_scores_codex":[0.9997247,0.00009731632,0.00001358543,0.00005809759,0.00003066428,0.00007562598],"domain_scores_gemma":[0.9994154,0.00005347923,0.00007970107,0.00004843367,0.00003351845,0.0003694879],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5682999,0.1616812,0.0157987,0.0008399356,0.00222097,0.0008255776,0.0005456787,0.006000643,0.1086201,0.0005615177,0.007223882,0.1273819],"study_design_scores_gemma":[0.3847623,0.5803081,0.01939187,0.00003348165,0.0005385037,0.0008221465,0.0001079503,0.001802213,0.007784889,0.0002330373,0.004174329,0.00004122722],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930428,0.001107771,0.0003857862,0.0004299092,0.00007994083,0.002063769,0.000960519,0.00008312737,0.001846321],"genre_scores_gemma":[0.9912279,0.001000518,0.001302916,0.0005893564,0.00008205882,0.001540351,0.002408829,0.00002298927,0.00182518],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003263794,"threshold_uncertainty_score":0.0109185,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05581443802025618,"score_gpt":0.4594876846142211,"score_spread":0.403673246593965,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}